Intended Use

The Early Bird is indicated for the introduction of catheters, catheter balloons, and other diagnostic and interventional devices into the femoral artery or femoral vein while maintaining hemostasis during diagnostic and interventional endovascular procedures. It provides physicians with an early indication of a potential internal bleeding complication by initial detection and monitoring of extravascular fluid accumulation.

Technology

The device consists of an introducer sheath with embedded electrodes connected to a battery-powered impedance analyzer within a user interface display. It monitors bioimpedance changes caused by extravascular fluid accumulation. The updated firmware improves detection by using an algorithm combining an impedance drop threshold and a bioimpedance slope threshold to trigger bleed level alerts, with software allowing reset functionality. No hardware changes were made.

Performance

Design verification and validation activities, including software verification, electrical testing, and prior animal validation studies, demonstrated reliable performance and safety of the enhanced detection algorithm. Risk analyses confirmed no unacceptable risks from algorithm changes. Verification and validation activities support substantial equivalence to the predicate device.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    1/31/2023

    3 months
  • 2

    FDA Approval

    5/25/2023

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.